Market Cap 1.12B
Revenue (ttm) 7.02M
Net Income (ttm) -157.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,248.72%
Debt to Equity Ratio 0.00
Volume 707,300
Avg Vol 777,544
Day's Range N/A - N/A
Shares Out 66.38M
Stochastic %K 21%
Beta 1.59
Analysts Strong Sell
Price Target $62.92

Latest News on CLDX

Celldex Therapeutics: Rising High, With Room For Further Growth

May 10, 2024, 10:44 AM EDT - 11 months ago

Celldex Therapeutics: Rising High, With Room For Further Growth


MoneyShow's Best Investment Ideas For 2024: Part 2

Jan 26, 2024, 5:30 PM EST - 1 year ago

MoneyShow's Best Investment Ideas For 2024: Part 2

ANET BAX BIP BLK BP CCJ CSTE